Brief: Acura Pharmaceuticals eligible to get reimbursement of development costs, royalties in connection with Bayer Healthcare agreement

Acura Pharmaceuticals

16/06/2015 11:34

June 16 (Reuters) - Acura Pharmaceuticals Inc  ACUR.O : 
 * To be eligible to receive reimbursement of development costs, success-based 
   development and regulatory milestones payments 
 * To receive low mid-single digit royalties on net sales of product in 
   countries with patent coverage,reduced royalty elsewhere 
 * Eligible to receive reimbursement of development costs, royalties, in 
   connection with license agreement with Bayer healthcare 
 
* Source text (http://1.usa.gov/1R3QhAr) 
* Further company coverage  ACUR.O   
 
((Bengaluru Newsroom; +1 646 223 8780))